Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification
Related Experiment Video
Updated: Oct 23, 2026

Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator
Published on: May 14, 2020
Abstract:
The Nuclear Regulatory Commission (NRC) is amending regulatory text and the response to a public comment contained in a final rule published in the Federal Register on Friday, December 2, 1994, entitled "Preparation, Transfer for Commercial Distribution, and Use of Byproduct Material for Medical Use." This action is necessary following reconsideration by the NRC regarding the requirements for the information to be included on labels for radioactive drugs to be transferred for commercial distribution. The effect of this action is to reduce regulatory burden and uncertainty for licensees that manufacture and distribute radiopharmaceuticals that contain byproduct material for medical use.
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Downstream Processing
Good Manufacturing Practices
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Upstream Processing
Production of Pharmaceuticals

